National Cancer Institute; Amended Notice of Meeting, 66732-66733 [2011-27868]
Download as PDF
<![CDATA[
66732
Federal Register / Vol. 76, No. 208 / Thursday, October 27, 2011 / Notices
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: October 21,2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27851 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meetings
wreier-aviles on DSK7SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Genomic
Research Grant R01 Applications on
Integrative Data Analysis for Vision Research.
Date: November 4, 2011.
Time: 8:30 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Anne E. Schaffner, PhD,
Chief, Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
Lane, Suite 1300, MSC 9300, 301–451–2020,
aes@nei.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Eye Institute
Special Emphasis Panel, NEI Clinical
Applications II.
Date: November 15, 2011.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health, NEI,
5635 Fishers Lane, Rockville, MD 20892
(Telephone Conference Call).
Contact Person: Anne E. Schaffner, PhD,
Chief, Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
VerDate Mar<15>2010
14:47 Oct 26, 2011
Jkt 226001
Lane, Suite 1300, MSC 9300, 301–451–2020,
aes@nei.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Eye Institute
Special Emphasis Panel, Vision Research
Grant Applications.
Date: December 5, 2011.
Time: 8:30 a.m. to 5 p.m
Agenda: To review and evaluate grant
applications,
Place: Embassy Suites Hotel at the Chevy
Chase Pavilion, 4300 Military Road, NW.,
Tenleytown I, Washington, DC 20015.
Contact Person: Daniel R. Kenshalo, PhD,
Scientific Review Officer, Division of
Extramural Research, National Eye Institute,
National Institutes of Health, 5635 Fishers
Lane, Suite 1300, MSC 9300, 301–451–2020,
kenshalod@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27833 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NST–2 Conflicts.
Dates: October 31–November 1, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street, NW., Washington, DC 20037.
Contact Person: JoAnn McConnell, PhD,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, (301) 496–5324,
mcconnej@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; T–32 Training Grant & R–25
NIH Summer Research Experience Program
Peer Review Meeting.
Dates: November 30–December 1, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Argonaut Hotel, 495 Jefferson Street,
San Francisco, CA 94109.
Contact Person: Phillip F. Wiethorn,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
NINDS/NIH/DHHS/Neuroscience Center,
6001 Executive Blvd., Suite 3208, MSC 9529,
Bethesda, MD 20892, (301) 496–5388,
wiethorp@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27822 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Clinical Trials and
Translational Research Advisory
Committee, November 9, 2011, 9 a.m. to
November 9, 2011, 4 p.m., National
Institutes of Health, Building 31, Cwing, 6th Floor, 31 Center Drive,
Conference Room 10, Bethesda, MD
20892 which was published in the
Federal Register on August 24, 2011,
76FR52960.
This notice is amended to add the
Clinical Trials Network Strategic
Planning ad hoc Subcommittee meeting
on November 8, 2011 from 7 p.m. to 9
p.m. at the Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Ave., Bethesda, MD. The meeting is
open to the public.
E:\FR\FM\27OCN1.SGM
27OCN1
Federal Register / Vol. 76, No. 208 / Thursday, October 27, 2011 / Notices
Cancer Control, National Institutes of Health,
HHS)
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27868 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
[FR Doc. 2011–27867 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Cancer Institute; Notice of
Closed Meeting
National Institutes of Health
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The purpose of this meeting
is to evaluate requests for preclinical
development resources, biologics,
clinical assays and other developmental
programs for potential new therapeutics
for the treatment of cancer. The outcome
of the evaluation will provide
information to internal NCI committees
that will decide whether NCI should
support requests and make available
contract resources for development of
the potential therapeutic to improve the
treatment of various forms of cancer.
The research proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material and
personal information concerning
individuals associated with the
proposed research projects, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
wreier-aviles on DSK7SPTVN1PROD with NOTICES
National Institutes of Health
National Cancer Institute; Notice of
Meetings
Name of Committee: National Cancer
Institute Special Emphasis Panel, Clinical
Assay Development Program (CADP).
Date: November 29, 2011.
Time: 8 a.m.–3 p.m.
Agenda: To review grant applications for
the CADP.
Place: Bethesda Marriott North Hotel, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Dr. Tracy Lively, Executive
Secretary, Clinical Assay Development
Program (CADP), National Cancer Institute,
NIH, 6130 Executive Boulevard, EPN/6042,
Bethesda, MD 20892, 301–496–1591,
livelyt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
VerDate Mar<15>2010
14:47 Oct 26, 2011
Jkt 226001
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meeting of the
National Cancer Advisory Board.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
A portion of the meeting will be
closed to the public as indicated below
in accordance with the provisions set
forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review,
discussion, and evaluation of individual
intramural programs and projects
conducted by the National Cancer
Institute, including consideration of
personnel qualifications and
performance, and the competence of
individual investigators, the disclosure
of which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Cancer
Advisory Board, Subcommittee on Global
Cancer Research.
Open: December 5, 2011, 6:30 p.m. to 8
p.m.
Agenda: Discussion on Global Cancer.
Place: Hyatt Regency Bethesda, One Metro
Center, Bethesda, MD 20814.
Contact Person: Dr. Ted Trimble, Executive
Secretary, NCAB Subcommittee on Global
Cancer Research, National Cancer Institute,
National Institutes of Health, 6130 Executive
Boulevard, EPN/7025, Rockville, MD 20892–
8345, (301) 496–2522, trimblet@mail.nih.gov.
Name of Committee: National Cancer
Advisory Board.
Open: December 6, 2011, 9 a.m. to 3:30
p.m.
Agenda: Program reports and
presentations; business of the Board.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
66733
Closed: December 6, 2011, 3:30 p.m. to 5
p.m.
Agenda: Review intramural program site
visit outcomes. Discussion of confidential
personnel issues.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, C Wing, 6th
Floor, Conference Room 10, Bethesda, MD
20892.
Contact Person: Dr. Paulette S. Gray,
Executive Secretary, National Cancer
Institute, National Institutes of Health, 6116
Executive Boulevard, 8th Floor, Room 8001,
Bethesda, MD 20892–8327, (301) 496–5147.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page:
deainfo.nci.nih.gov/advisory/ncab.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: October 21, 2011
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–27865 Filed 10–26–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2) notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections 552b(c)
(4) and 552b(c) (6), Title 5 U.S.C., as
amended. The purpose of this meeting
is to evaluate requests for preclinical
E:\FR\FM\27OCN1.SGM
27OCN1
]]>Agencies
[Federal Register Volume 76, Number 208 (Thursday, October 27, 2011)]
[Notices]
[Pages 66732-66733]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-27868]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Clinical Trials and Translational Research Advisory
Committee, November 9, 2011, 9 a.m. to November 9, 2011, 4 p.m.,
National Institutes of Health, Building 31, C-wing, 6th Floor, 31
Center Drive, Conference Room 10, Bethesda, MD 20892 which was
published in the Federal Register on August 24, 2011, 76FR52960.
This notice is amended to add the Clinical Trials Network Strategic
Planning ad hoc Subcommittee meeting on November 8, 2011 from 7 p.m. to
9 p.m. at the Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Ave., Bethesda, MD. The meeting is open to the public.
[[Page 66733]]
Dated: October 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-27868 Filed 10-26-11; 8:45 am]
BILLING CODE 4140-01-P
